How MIEBO may help
MIEBO is an FDA-approved prescription eye drop that's been studied in over 600 people. Keep reading to see the proven results of MIEBO.
In clinical studies, MIEBO
was shown to:
Significantly reduce
signs of dry eye*
With continued use of MIEBO, doctors saw improvements in the damage on the surface of the eye.
*MIEBO was studied against saline in 2 clinical trials of more than 1200 patients who were treated 4 times per day.
In clinical studies, MIEBO
was shown to:
Significantly reduce
symptoms of dry eye*
People in the studies felt their eye dryness significantly improved.
*MIEBO was studied against saline in 2 clinical trials of more than 1200 patients who were treated 4 times per day.
Relief in as little as 2 weeks
In the studies, doctors checked the signs and symptoms of dry eye after 2 weeks, and again after 8 weeks. Patients saw significant improvement at both checkpoints while they were continuing to use MIEBO.
Side effects with MIEBO are uncommon
MIEBO is a prescription eye drop approved by the FDA. Because it’s a prescription, it was studied in-depth in patients, unlike over-the-counter artificial tears.
The safety of MIEBO was studied in more than 600 people in 2 clinical trials that lasted 57 days (GOBI and MOJAVE). No serious side effects were seen in either study. The data below is an average of the studies.
0
Serious side effects
No one treated with MIEBO experienced serious side effects.
0.5%
felt burning or stinging
Very few people reported burning or stinging when putting in MIEBO (GOBI: 3 people; MOJAVE: 0 people).
0.2%
stopped using MIEBO due to side effects
Of the 614 people studied, only 1 person stopped using MIEBO because of side effects (GOBI: 1 person; MOJAVE: 0 people).
2.1%
reported blurred vision
The most common side effect seen with MIEBO was blurred vision, which occurred in 2.1% of people. It usually resolved within minutes (GOBI: 9 people; MOJAVE: 4 people). 0.8% of people also experienced eye redness.
How MIEBO works
MIEBO works differently
See how MIEBO protects against too much tear evaporation.
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
